SPC356
Apalútamíð
Status:
VeittApplication date:
2.11.2021Application published:
15.12.2021Grant published:
15.6.2025
Max expiry date:
15.1.2034Medicine name:
ErleadaMedicine for children:
No
Timeline
Today
2.11.2021Application
15.12.2021Publication
15.6.2025Registration
15.1.2034Expires
Marketing license
IS authorization number:
EU/1/18/1342/001-003Date:
22.1.2019
Foreign authorization number:
EU/1/18/1342Date:
14.1.2019
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024 US
Name:
Sloan Kettering Institute For Cancer ResearchAddress:
1275 New York Avenue, New York, NY US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3533792